These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26324350)

  • 1. The Role of p110δ in the Development and Activation of B Lymphocytes.
    Newman R; Turner M
    Adv Exp Med Biol; 2015; 850():119-35. PubMed ID: 26324350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
    Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
    Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of B-cell intracellular signaling by monitoring the PI3K-Akt axis in patients with common variable immunodeficiency and activated phosphoinositide 3-kinase delta syndrome.
    Del Pino-Molina L; Torres Canizales JM; Rodríguez-Pena R; López-Granados E
    Cytometry B Clin Cytom; 2021 Jul; 100(4):460-466. PubMed ID: 32961022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.
    So L; Yea SS; Oak JS; Lu M; Manmadhan A; Ke QH; Janes MR; Kessler LV; Kucharski JM; Li LS; Martin MB; Ren P; Jessen KA; Liu Y; Rommel C; Fruman DA
    J Biol Chem; 2013 Feb; 288(8):5718-31. PubMed ID: 23275335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K in lymphocyte development, differentiation and activation.
    Okkenhaug K; Vanhaesebroeck B
    Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.
    Glassford J; Vigorito E; Soeiro I; Madureira PA; Zoumpoulidou G; Brosens JJ; Turner M; Lam EW
    Eur J Immunol; 2005 Sep; 35(9):2748-61. PubMed ID: 16114097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML.
    Goodwin CB; Li XJ; Mali RS; Chan G; Kang M; Liu Z; Vanhaesebroeck B; Neel BG; Loh ML; Lannutti BJ; Kapur R; Chan RJ
    Blood; 2014 May; 123(18):2838-42. PubMed ID: 24553178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.
    Bilancio A; Okkenhaug K; Camps M; Emery JL; Ruckle T; Rommel C; Vanhaesebroeck B
    Blood; 2006 Jan; 107(2):642-50. PubMed ID: 16179367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation.
    Al-Alwan MM; Okkenhaug K; Vanhaesebroeck B; Hayflick JS; Marshall AJ
    J Immunol; 2007 Feb; 178(4):2328-35. PubMed ID: 17277138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phosphoinositide 3-kinase-Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptors.
    Fallah MP; Chelvarajan RL; Garvy BA; Bondada S
    Mech Ageing Dev; 2011; 132(6-7):274-86. PubMed ID: 21645538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.
    Janas ML; Hodson D; Stamataki Z; Hill S; Welch K; Gambardella L; Trotman LC; Pandolfi PP; Vigorito E; Turner M
    J Immunol; 2008 Jan; 180(2):739-46. PubMed ID: 18178811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.
    Aragoneses-Fenoll L; Ojeda G; Montes-Casado M; Acosta-Ampudia Y; Dianzani U; Portolés P; Rojo JM
    Front Immunol; 2018; 9():332. PubMed ID: 29535720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
    Papakonstanti EA; Zwaenepoel O; Bilancio A; Burns E; Nock GE; Houseman B; Shokat K; Ridley AJ; Vanhaesebroeck B
    J Cell Sci; 2008 Dec; 121(Pt 24):4124-33. PubMed ID: 19033389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
    Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
    J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.
    So L; Fruman DA
    Biochem J; 2012 Mar; 442(3):465-81. PubMed ID: 22364281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T and B-cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity.
    Preite S; Gomez-Rodriguez J; Cannons JL; Schwartzberg PL
    Immunol Rev; 2019 Sep; 291(1):154-173. PubMed ID: 31402502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
    Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
    Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecules in medicine mini-review: isoforms of PI3K in biology and disease.
    Vanhaesebroeck B; Whitehead MA; Piñeiro R
    J Mol Med (Berl); 2016 Jan; 94(1):5-11. PubMed ID: 26658520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion.
    Luk SK; Piekorz RP; Nürnberg B; Tony To SS
    Eur J Cancer; 2012 Jan; 48(1):149-57. PubMed ID: 22079609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.